Comera Life Sciences

Excipients for Biologics

Comera Life Sciences is dedicated to providing self-injectable biologics to patients and converting biologics from an intravenous to subcutaneous administration. Success in these missions can give patients their lives back, not needing to spend such a large portion of time in the hospital to receive treatment. Other goals of Comera’s science are to lower the risk of infection and decrease the cost of necessary medications. Some indications in their pipeline include cancer, cardiovascular disease, and inflammatory bowel disease. Their team includes experts in protein chemistry and formulation science. Comera, founded in 2014, proclaims to be a compassion-driven company with health and safety commitments to their employees.